Eric Horler, AIQ Solutions CEO, was invited by AdvaMed to present our TRAQinform IQ technology at a reception showcasing AI-enabled medical devices and technologies. The event provided more clarity to lawmakers on how AI imaging technologies are shaping the way medical providers

Hope to see you in Toronto!

https://t.co/Iv1ev5cDMo

https://t.co/EXWn8Eejdw

congratulations @JakeKendrick01 on your PhD from all your friends at @aiq_solutions @AiqAustralia

@TROGfightcancer @TimothyGPerk @aiq_solutions Great presentation today by our VP of Research Tim Perk explaining our exciting results for AI powered simulated targeted ablation, a new horizon for #radiationoncology

AIQ is at #ViVE2024! Come by and chat with our CEO Eric Horler to learn about our new technology for oncologists managing patients with late-stage cancers. #PrecisionMedicine

Congratulations to @MikaelaDellOro at The University of Western Australia and @TimothyGPerk, AIQ's VP of Research. Our latest collaboration was accepted as an abstract in the upcoming #TROG 2024 ASM. Click here to learn more about AIQ's technologies: https://t.co/0xOpmqwH9K.

ViVE, digital health conference of the year, is fast approaching. AIQ Solutions will exhibit to showcase our clinical decision support tool for oncologists. Schedule a meeting with our CEO Eric Horler today at info@aiq-solutions.com! #vive2024 #digitalhealth

Congratulations to Diana Grace Varghese and her colleagues at @theNCI. Our latest collaboration was accepted as an abstract at the upcoming #ENETS 2024 conference. Click here to learn more about AIQ's technologies:  https://t.co/0xOpmqwH9K.

Another Successful #GU24! The AIQ team had many positive meetings with current and potential customers as well as research collaborators.  If you would like to learn more about our Early Access Program, contact Jackie Hind at jackie.hind@aiq-solutions.com.

AIQ is at ASCO #GU24! Come by to learn about our new technology for clinical decision support in late-stage cancer. Ask about our Early Access Program!

Thank you @VMurthymed for presenting this poster at the PSMA Conference last week. It's now available  on the AIQ website. Click here to learn more: https://t.co/Aw0Nk3sGLk

AIQ will be at ASCO #GU24 next week showcasing the latest TRAQinform IQ reports from our FDA-cleared, clinical decision support tool for oncologists. Schedule a meeting with our CEO, Eric Horler or Director of Early Access Program, Jackie Hind. See you soon!

Automated quantification of PSMA-positive and -negative regions of interest is available now to support clinical decisions for targeted radionuclide therapy. Don’t miss out on the chance to learn more from Eric Horler today at AIQ’s table at the PSMA Conference. #PSMA

AIQ has developed an FDA-cleared, clinical decision support tool for oncologists to use to better understand heterogeneity of change during the course of treatment for late-stage cancer.   Click here to learn more about our Early Access Program: https://t.co/mXx7vlwZyn.

AIQ is a proud sponsor of the first annual PSMA Conference co-sponsored by @UCSFHospitals, @UCLAHealth, and @PCFnews. Come and visit AIQ at our table or schedule a meeting with our CEO Eric Horler in advance at info@aiq-solutions.com

AIQ is proud to be featured as a success story by the Wisconsin Economic Development Corporation (@WEDCNews) for our innovative technology used by oncologists treating patients with advanced cancers. https://t.co/liSf9rIICm.   Learn more about AIQ Solutions at

TRAQinform IQ Technology will be featured in a poster presentation by @VMurthymed from @UCLA at the first annual PSMA Conference. Please stop by to check it out. Learn more about our technology at https://t.co/jE09V7B9UQ

“The secret of change is to focus all of your energy, not on fighting the old, but on building the new.” —Socrates AIQ Solutions wishes you a New Year filled with infinite possibilities!